Actively Recruiting
HoLEP vs BipolEP in Management of BPH Patients With Large Prostates
Led by Assiut University · Updated on 2025-07-24
98
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a non-inferiority prospective randomized comparative clinical trial aiming to prove the non-inferiority of bipolar enucleation of the prostate in comparison to holmium laser enucleation of the prostate in management of benign prostatic hyperplasia patients with large prostates and in turn its feasibility as an alternative procedure in hospitals with limited resources
CONDITIONS
Official Title
HoLEP vs BipolEP in Management of BPH Patients With Large Prostates
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >50 years
- Prostate volume >80 ml
- Failure of or noncompliance with medical treatment
- IPSS >15
- Qmax <15 ml/sec
- Urinary retention and fixed catheters with poor results on trial of voiding without catheter
You will not qualify if you...
- Patients with active urinary tract infection
- Prostate cancer
- Bladder carcinoma
- Urethral stricture
- Neurogenic bladder disorders
- Redo cases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assiut University Urology Hospital
Asyut, Egypt
Actively Recruiting
Research Team
M
Mostafa M. Mostafa, M.D.
CONTACT
M
Mohammad A. Abd ElMoneim, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here